Evidence map›Paper›PMID 32982962›Full record

ArticleFrontiers in endocrinology2020

A Multicenter Retrospective Study of 58 Patients With Primary Thyroid Diffuse Large B Cell Lymphoma.

Jianing Yi, Pingyong Yi, Wei Wang, Huan Wang, Xinyu Wang, Hanjia Luo, Peizhi Fan

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in Frontiers in endocrinology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.8field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Clinicopathological and genetic analyses of thyroid large B-cell lymphoma in a Japanese population.Journal of clinical and experimental hematopathology : JCEH · 2024
    Article
  6. Diffuse large B-cell lymphoma withClinical case reports · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Prognostic Nomogram and Competing Risk Analysis of Death for Primary Thyroid Lymphoma: A Long-term Survival Study of 1638 Patients.Annals of surgery open : perspectives of surgical history, education, and clinical approaches · 2022
    Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Jianing YiSurgical Department of Breast and Thyroid Gland, The First Affiliated Hospital of Hunan Normal University/Hunan Provincial People's Hospital, Changsha, China.
Pingyong YiDepartment of Oncology, Changsha Kexin Cancer Hospital, Changsha, China.
Wei WangDepartment of Oncology, Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.
Huan WangSurgical Department of Breast and Thyroid Gland, Xiangya Second Hospital of Central South University, Changsha, China.
Xinyu WangSurgical Department, Xiangya Hospital of Central South University, Changsha, China.
Hanjia LuoDepartment of Oncology, Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.
Peizhi FanSurgical Department of Breast and Thyroid Gland, The First Affiliated Hospital of Hunan Normal University/Hunan Provincial People's Hospital, Changsha, China.
Central South University · CNHunan Normal University · CNXiangya Hospital Central South University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Combined Modality TherapyFemaleFollow-Up StudiesHumansLymphoma, Large B-Cell, DiffuseMaleMiddle AgedPrognosisRetrospective StudiesSurvival RateThyroid Neoplasmslarge B-celllymphomaprognosisthyroidtreatment

Identifiers

PMID32982962
PMCPMC7483576
OpenAlexW3080492093

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.